]>
IRCT20090905002417N20 IRCT 2018-03-21 Esfahan University of Medical Sciences Effect of Allopurinol on renal residual function Study of the effect of Allopurinol on renal residual function in hyperuricemic peritoneal dialysis patients 2017-03-21 anticipated 98 Complete https://irct.ir/trial/2130 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: simple randomization, table of random numbers, Blinding description: participants, nurses and investigator are blinded in this study. N/A end stage renal disease. Intervention 1: Intervention group: Allopurinol tablet usage, 100mg daily orally for 6 months manufactured by Jalinous company. Intervention 2: Control group: no drug use. Yes - There is a plan to make this available What will be shared: Primary outcome measure could be shared after termination of study. When: starting 1 year after publication To whom: Academic institution can apply to recieve it Conditions: using data for similar studies Where to obtain: get documents by e-mail adress to information provider How to obtain: After introduce and academic information, please explain your aim(s). they must committal to refer this study as reference if they use data. otherwise we entitle to follow these to Ethic commitee. Comments:
public Dr. Elham kabiri
Alzahra hospital, Sofe Avenue, Isfahan
Isfahan Iran (Islamic Republic of) 8174675731 +98 31 3668 5555 Kabirielham20@gmail.com Esfahan University of Medical Sciences scientific Dr. Firouzeh Moeinzadeh
Alzahra hospital, Sofe Avenue. Isfahan
Isfahan Iran (Islamic Republic of) 8174675731 +98 31 3668 5555 fimoinzad@yahoo.com Esfahan University of Medical Sciences Iran (Islamic Republic of) consent for cooperation peritoneal dialysis for at least 3 months 18-80 years old hyperuricemia: uric acid level ≥7mg/dL in men and ≥6mg/dL in women minimum residual renal function : 2cc/min/m2 18 years 80 years Both death allopurional allergy or complications hemodialysis rout for dialysis renal transplantation nephrotoxic drug use N18.0 end stage renal disease Treatment - Drugs Placebo Intervention group: Allopurinol tablet usage, 100mg daily orally for 6 months manufactured by Jalinous company Control group: no drug use Serum uric acid level. Timepoint: before intervention and 6 months after drug use. Method of measurement: laboratory kit- ELISA- with HITACHI equipment. Residual renal function. Timepoint: before intervention and 6 months after drug use. Method of measurement: renal function formula. Esfahan University of Medical Sciences Approved 2017-01-11 Ethics comittee of Vice Chancellor for Research, Isfahan University of Medical Sciences Hezar jarib street, Isfahan Isfahan Isfehan Iran (Islamic Republic of)